A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.

A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplant. 1995 Nov; 16(5):655-61.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow Transplantation
Combined Modality Therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor
Hematopoietic Stem Cell Transplantation
Humans
Interleukin-3
Male
Middle Aged
Neoplasms

authors with profiles

Wendy Stock